BHVN Competitors & Alternatives
Compare Biohaven Ltd. with similar stocks in the same industry
Biotechnology
BHVN
Main Stock$13.91
+0.62%
Tradestie Score
42
Market Cap
$1.57B
Analyst Upside
+70.7%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AGIO
Agios Pharmaceuticals, Inc.
|
$30.42
-3.70%
|
$2.33B | - | 59 | Compare |
|
GLPG
Galapagos NV
|
$27.73
-3.75%
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$2.91
-8.79%
|
$2.23B | - | 50 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$28.00
-3.58%
|
$2.22B | - | 45 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$49.90
-1.48%
|
$2.21B | - | 59 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.33
-2.19%
|
$2.18B | - | 51 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.47
-6.03%
|
$2.08B | - | 33 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$15.14
-5.76%
|
$2.02B | 802.5 | 41 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$10.00
+3.09%
|
$2.01B | - | 49 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$27.45
-3.89%
|
$1.97B | - | 39 | Compare |
More BHVN Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry